DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

3INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Abt-594, 198283-73-7, Tebanicline [inn], Ebanicline, 5-[[(2r)-azetidin-2-yl]methoxy]-2-chloropyridine, 9kx8nkv538

Molecular Formula

C₉H₁₁ClN₂O

Molecular Weight

198.65 g/mol

InChI Key

MKTAGSRKQIGEBH-SSDOTTSWSA-N

FDA UNII

9KX8NKV538

1 2D Structure

Tebanicline

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[[(2R)-azetidin-2-yl]methoxy]-2-chloropyridine

2.1.2 InChI

InChI=1S/C9H11ClN2O/c10-9-2-1-8(5-12-9)13-6-7-3-4-11-7/h1-2,5,7,11H,3-4,6H2/t7-/m1/s1

2.1.3 InChI Key

MKTAGSRKQIGEBH-SSDOTTSWSA-N

2.1.4 Canonical SMILES

C1CNC1COC2=CN=C(C=C2)Cl

2.1.5 Isomeric SMILES

C1CN[C@H]1COC2=CN=C(C=C2)Cl

2.2 Other Identifiers

2.2.1 UNII

9KX8NKV538

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 5-(2-azetidinylmethoxy)-2-chloropyridine

2. Abt 594

3. Abt-594

2.3.2 Depositor-Supplied Synonyms

1. Abt-594

2. 198283-73-7

3. Tebanicline [inn]

4. Ebanicline

5. 5-[[(2r)-azetidin-2-yl]methoxy]-2-chloropyridine

6. 9kx8nkv538

7. Abt594

8. Chembl430497

9. Unii-9kx8nkv538

10. (r)-5-(2-azetidnylmethoxy)-2-chloropyridine

11. 5-((2r)-azetidinylmethoxy)-2-chloropyridine

12. Pyridine, 5-(2-azetidnylmethoxy)-2-chloro-, (r)-

13. Tebeniciline

14. Tebanicline [mi]

15. Tebanicline(abt-594)

16. (r)-5-(azetidin-2-ylmethoxy)-2-chloropyridine

17. Schembl120178

18. Gtpl3989

19. Dtxsid90173555

20. Bcp19181

21. Ex-a2483

22. Zinc3959783

23. Bdbm50062641

24. Akos006280361

25. (r)-2-chloro-5-(2-azetidinylmethoxy)pyridine

26. 5-((r)-1-azetidin-2-ylmethoxy)-2-chloro-pyridine

2.4 Create Date

2005-08-09

3 Chemical and Physical Properties

Molecular Formula	C₉H₁₁ClN₂O
Molecular Weight	198.65 g/mol
XLogP3	1.6
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	3
Exact Mass	198.0559907 g/mol
Monoisotopic Mass	198.0559907 g/mol
Topological Polar Surface Area	34.2 Å²
Heavy Atom Count	13
Formal Charge	0
Complexity	168
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1